Insiders · Profile

Doberstein Stephen K

SVP & Chief Scientific Officer at NEKTAR THERAPEUTICS. Filing since 17 Feb 2016. CIK 0001480111

Company
Date
Role
Action
Shares
Amount
Of holding
5 Sep 2019
SVP & Chief Scientific Officer
Bought
15,000
$259.20K
16.2%
16 Aug 2019
SVP & Chief Scientific Officer
Sold, plan not stated
3,245
$58.90K
3.4%
16 May 2019
SVP & Chief Scientific Officer
Sold, plan not stated
3,461
$108.57K
3.5%
19 Feb 2019
SVP & Chief Scientific Officer
Sold, plan not stated
3,310
$140.31K
3.2%
16 Nov 2018
SVP & Chief Scientific Officer
Sold, plan not stated
4,524
$173.04K
5.4%
16 May 2018
SVP & Chief Scientific Officer
Sold, plan not stated
3,435
$286.44K
5.1%
9 Apr 2018
SVP & Chief Scientific Officer
Sold, plan not stated
49,500
$4.76M
42.3%
6 Apr 2018
SVP & Chief Scientific Officer
Sold, plan not stated
110,500
$10.13M
62.1%
16 Feb 2018
SVP & Chief Scientific Officer
Sold, plan not stated
2,426
$201.21K
3.5%
8 Nov 2017
SVP & Chief Scientific Officer
Sold, plan not stated
300,000
$9.03M
90.6%
7 Nov 2017
SVP & Chief Scientific Officer
Sold, plan not stated
75,409
$1.94M
70.8%
6 Nov 2017
SVP & Chief Scientific Officer
Sold, plan not stated
20,914
$522.43K
40.2%
5 Oct 2017
SVP & Chief Scientific Officer
Sold, plan not stated
43,677
$1.09M
58.4%
16 Aug 2017
SVP & Chief Scientific Officer
Sold, plan not stated
1,701
$32.86K
5.2%
16 May 2017
SVP & Chief Scientific Officer
Sold, plan not stated
1,701
$33.25K
4.9%
5 Apr 2017
SVP & Chief Scientific Officer
Sold, plan not stated
100,000
$2.17M
74.3%
16 Feb 2017
SVP & Chief Scientific Officer
Sold, plan not stated
1,261
$16.57K
3.5%
16 Nov 2016
SVP & Chief Scientific Officer
Sold, plan not stated
670
$9.35K
3.5%
16 Aug 2016
SVP & Chief Scientific Officer
Sold, plan not stated
1,336
$23.46K
6.6%
17 May 2016
SVP & Chief Scientific Officer
Sold, plan not stated
339
$4.60K
24.9%
17 Feb 2016
SVP & Chief Scientific Officer
Sold, plan not stated
390
$4.65K
44.6%
21 decisions on file.